猪用灭活猪鼻支原体疫苗的效力研究
本研究在3周龄剖宫产初乳剥夺仔猪中评估灭活猪鼻支原体疫苗的效力,设高、中、低三剂量组与安慰剂对照组,免疫后3周攻毒,观察跛行和呼吸道症状3周后行大体病理评估。中剂量疫苗(每2.0 mL至少7.41×10^7 CCU)较安慰剂显著减少跛行和心包炎,预防分数分别为0.76(95%CI [0.26, 0.92])和0.58(95%CI [0.31, 0.74]),并显著提高攻毒后平均日增重(0.92 lbs/day vs 0.57 lbs/day,P < .0001)。
要点
- 中剂量疫苗定义为每2.0 mL含至少7.41×10^7 CCU的猪鼻支原体。
- 中剂量疫苗较安慰剂显著减少跛行,预防分数0.76(95%CI [0.26, 0.92])。
- 中剂量疫苗较安慰剂显著减少心包炎,预防分数0.58(95%CI [0.31, 0.74])。
核心结论
- 灭活猪鼻支原体疫苗可显著减少攻毒后仔猪的跛行和心包炎,并显著提高攻毒后平均日增重。
研究设计与样本
- 研究在3周龄剖宫产初乳剥夺仔猪中评估灭活猪鼻支原体疫苗,设高、中、低三剂量组与安慰剂对照组,免疫后3周攻毒,攻毒后观察3周。
主要发现
- 中剂量疫苗较安慰剂对照组显著减少跛行,预防分数为0.76(95%CI [0.26, 0.92])。
- 中剂量疫苗较安慰剂对照组显著减少心包炎,预防分数为0.58(95%CI [0.31, 0.74])。
- 中剂量疫苗组攻毒后平均日增重为0.92 lbs/day,安慰剂组为0.57 lbs/day,差异显著(P < .0001)。
关键数值与推荐
- 最低免疫剂量定义为每2.0 mL剂量含至少7.41×10^7 CCU的猪鼻支原体,以中剂量疫苗为代表。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Lameness and polyserositis in pigs caused by Mycoplasma hyorhinis are generally treated with antibiotics and may require multiple doses. The costs of these antibiotics combined with economic losses from culling and reduced feed conversion due to lameness are hardships to the swine producer. In this study we have demonstrated efficacy of an inactivated M. hyorhinis vaccine administered to three-week old caesarian-derived colostrum-deprived piglets. Three doses of vaccine (high, medium, and low) were evaluated and compared to a placebo control. Mycoplasma hyorhinis challenge occurred three weeks after vaccination. Pigs were observed for lameness and respiratory distress for three weeks following challenge. Pigs were then euthanized and a gross pathological evaluation for polyserositis and arthritis was performed. A minimum immunizing dose of vaccine was defined as containing at least 7.41 × 107 CCU of M. hyorhinis per 2.0 mL dose as represented by the medium dose vaccine. This vaccine provided significant reductions in lameness and pericarditis with preventive fractions of 0.76 (95% CI [0.26, 0.92]) and 0.58 (95% CI [0.31, 0.74]), respectively, compared to the placebo control group. A significant increase in post-challenge weight gain (P < .0001) was also achieved with this vaccine, with an average daily gain (ADG) of 0.92 lbs/day compared to 0.57 lbs/day in the placebo group.
引用
- Martinson B, Zoghby W, Barrett K, et al. Efficacy of an inactivated Mycoplasma hyorhinis vaccine in pigs. Vaccine. 2017. PMID: 29221894. doi:10.1016/j.vaccine.2017.11.063
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。